Institutional Ownership
Liminatus Pharma Inc.
CUSIP 53271X116*W EXP 04/30/203LIMNWQ1 2026
Earnings
Quarterly EPS and revenue are sourced from SEC XBRL financial statements. We ingest the top issuers first; this fills in as coverage expands (or this security isn't mapped to an SEC filer yet).